recurrent oropharyngeal cancer
Showing 1 - 25 of >10,000
Metastatic Oropharyngeal Carcinoma, Recurrent Oropharyngeal Carcinoma Trial in Nashville (DNA Vaccine, Human Papillomavirus
Not yet recruiting
- Metastatic Oropharyngeal Carcinoma
- Recurrent Oropharyngeal Carcinoma
- DNA Vaccine
- +6 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Mar 22, 2023
Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +23 more
- Biospecimen Collection
- +2 more
-
Los Angeles, California
- +1 more
Jul 7, 2022
Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication
Completed
- Caregiver
- +37 more
- Communication Intervention
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 14, 2022
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +24 more
- Carboplatin
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 18, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +26 more
- Biopsy
- +5 more
-
Newark, Delaware
- +52 more
Feb 2, 2023
Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous
Active, not recruiting
- Metastatic Head and Neck Squamous Cell Carcinoma
- +9 more
- Carboplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 27, 2022
Circulating Biomarkers in Oropharyngeal Cancers
Active, not recruiting
- Oropharynx Squamous Cell Carcinoma
- +3 more
-
Orebro, SwedenAnna Oldaeus Almerén
Jun 13, 2023
Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC
Recruiting
- Head and Neck Carcinoma
- Adult Disease
- HPVDC injection level dose 1
- +3 more
-
Villejuif, FranceGustave Roussy
Aug 17, 2023
Single and Combined Modality Trans-Oral Robotic Surgery in Early
Not yet recruiting
- Cancer Head Neck
- Molecular Analysis
- Radiomic/ Morphological analysis
- (no location specified)
Jul 3, 2023
Pulsed Radiofrequency, Super Voltage Pulsed Radiofrequency, Glossopharyngeal Nerve Trial in Cairo (Supervoltage pulsed
Recruiting
- Pulsed Radiofrequency
- +4 more
- Supervoltage pulsed radiofrequency glossopharyngeal nerve block
- Standard voltage pulsed radiofrequency glossopharyngeal nerve block
-
Cairo, EgyptCairo University
Nov 8, 2023
Oropharyngeal Squamous Cell Carcinoma (SCC) Trial run by the National Cancer Institute (NCI) (PRGN-2009, Pembrolizumab)
Not yet recruiting
- Oropharyngeal Squamous Cell Carcinoma (SCC)
- PRGN-2009
- Pembrolizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 22, 2023
HPV-associated Oropharyngeal Cancer
Recruiting
- PREDICTIVE BIOMARKERS
- +2 more
- HPV-ASSOCIATED OROPHARYNGEAL CANCER
-
Rome, Italy"Regina Elena" National Cancer Institute
Oct 19, 2023
Oropharyngeal Cancer, Squamous Cell Carcinoma of the Oropharynx Trial in Ann Arbor (procedure, combination product, other,
Recruiting
- Oropharyngeal Cancer
- Squamous Cell Carcinoma of the Oropharynx
- Surgery
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
May 30, 2023
or Chemoradiotherapy Patient Care in Oropharyngeal Cancer
Recruiting
- Oropharyngeal Carcinoma
- Electronic Health Record Review
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Nov 11, 2022
Head and Neck Squamous Cell Carcinoma, Cancer, Cancer of Head and Neck Trial in United States (Pembrolizumab, Radiation therapy,
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Pembrolizumab
- +2 more
-
Tucson, Arizona
- +6 more
Oct 7, 2021
Oropharynx Cancer Trial in Miami (MRIdian Linac)
Not yet recruiting
- Oropharynx Cancer
- MRIdian Linac
-
Miami, FloridaThe University of Miami Sylvester Comprehensive Cancer Center
May 5, 2023
People Living With HIV, Oral and Oropharyngeal Cancer, and
Not yet recruiting
- HIV Infections
- +2 more
- Group Meeting (Focus Group)
- Questionnaires
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 20, 2023
Oral Cancer, Pharynx Cancer, Sleep Apnea Trial (Ronco-Onco and MAD)
Not yet recruiting
- Oral Cancer
- +4 more
- Ronco-Onco and MAD
- (no location specified)
Jan 30, 2023
HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in United States (Cisplatin-based Radiation Therapy, Cisplatin
Recruiting
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- Cisplatin-based Radiation Therapy
- Cisplatin Chemotherapy
-
Beverly Hills, California
- +3 more
Jul 6, 2022
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +21 more
- Atezolizumab
- +8 more
-
Little Rock, Arkansas
- +97 more
Jan 27, 2023
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +35 more
- PI3K inhibitor BKM120
- cetuximab
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Sep 14, 2021
Using Human Papillomavirus DNA Testing to Detect HPV-Related
Recruiting
- Oropharyngeal Cancer
- +2 more
- NavDx
-
Basking Ridge, New Jersey
- +6 more
Apr 3, 2023
Post-treatment Surveillance in HPV+ Oropharyngeal SCC
Recruiting
- HPV
- Oropharyngeal Squamous Cell Carcinoma
- Screening
-
Boston, MassachusettsDana Farber Cancer Institute
Jun 8, 2022
Liposomal Bupivacaine and Transoral Robotic Surgery
Not yet recruiting
- Oropharyngeal Cancer
- +3 more
- Liposomal bupivacaine
-
Danville, PennsylvaniaGeisinger Medical Center
May 8, 2023